CoChat

Dihydromyricetin attenuates Escherichia coli lipopolysaccharide-induced ileum injury in chickens by inhibiting NLRP3 inflammasome and TLR4/NF-κB signalling pathway

Open access
Chang, Yicong, Yuan, Liang, Liu, Jiarui, Muhammad, Ishfaq, Cao, Chuanbao, Shi, Chenxi, Zhang, Yuanyuan, Li, Rui, Li, Changwen, Liu, Fangping · 2020 · Veterinary Research

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Abstract

Lipopolysaccharide (LPS) as a major component of Escherichia coli cell wall can cause inflammation and cell death. Dihydromyricetin (ampelopsin, DHM) is a natural flavonoid compound with anti-inflammatory, anti-oxidant and anti-bacterial effects. The preventive effects of DHM against ileum injury remain unclear. Here, we explored the protective role of DHM against LPS-induced ileum injury in chickens. In this study, DHM significantly attenuated LPS-induced alteration in diamine oxidase, malondialdehyde, reduced glutathione, glutathione peroxidase and superoxide dismutase levels in chicken plasma and ileum. Histology evaluation showed that the structure of blood vessels in ileum was seriously fragmented and presence of necrotic tissue in the lumen in the LPS group. Scanning electron microscopic observation revealed that the surface of the villi was rough and uneven, the structure was chaotic, and the normal finger shape was lost in the LPS group. In contrast, 0.05% and 0.1% DHM treatment partially alleviated the abnormal morphology. Additionally, DHM maintained the barrier function by restoring the protein expression of occludin, claudin-1 and zonula occludens protein-1. DHM inhibited apoptosis through the reduction of the expression of bax and caspase-3 and restored the expression of bcl-2. Importantly, DHM could reduce ileum NLR family pyrin domain-containing 3 (NLRP3), caspase-1, interleukin (IL)-1β and IL-18 expression to protect tissues from pyroptosis and inhibited toll-like receptor 4 (TLR4)/nuclear factor kappa-B (NF-κB) signalling pathway. In summary, DHM attenuated the ileum mucosal damage, oxidative stress and apoptosis, maintained barrier function, inhibited NLRP3 inflammasome and TLR4/NF-κB signalling pathway activation triggered by Escherichia coli LPS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13567-020-00796-8

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Effects of 0.025%, 0.05% and 0.1% DHM on LPS-induced ileum injury and oxidative stress. Changes of DAO activity (A) in plasma, DAO activity (B), MDA content (C), SOD activity (D), GSH content (E) and GSH-Px activity (F) in ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Values are expressed as the mean ± SD for each group (n = 5). *p < 0.05 and **p < 0.01 represented all groups compared with the control group. #p < 0.05 and ##p < 0.01 represented all groups compared with the LPS group.
Figure 1 Effects of 0.025%, 0.05% and 0.1% DHM on LPS-induced ileum injury and oxidative stress. Changes of DAO activity (A) in plasma, DAO activity (B), MDA content (C), SOD activity (D), GSH content (E) and GSH-Px activity (F) in ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Values are expressed as the mean ± SD for each group (n = 5). *p < 0.05 and **p < 0.01 represented all groups compared with the control group. #p < 0.05 and ##p < 0.01 represented all groups compared with the LPS group.CC BY · PubMed Central
Figure 2 Chickens ileum pathology. Ileum sections were stained by haematoxylin and eosin. All the ileum sections were examined by light microscopy and the images were displayed at 100X the original magnification. (A) Control group; (B) LPS group; (C) 0.025% DHM + LPS group; (D) 0.05% DHM + LPS group; (E) 0.1% DHM + LPS group; (F) 0.1% DHM group.
Figure 2 Chickens ileum pathology. Ileum sections were stained by haematoxylin and eosin. All the ileum sections were examined by light microscopy and the images were displayed at 100X the original magnification. (A) Control group; (B) LPS group; (C) 0.025% DHM + LPS group; (D) 0.05% DHM + LPS group; (E) 0.1% DHM + LPS group; (F) 0.1% DHM group.CC BY · PubMed Central
Figure 3 Scanning electron microscope (SEM) observation. SEM observation for ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. (A/D) Control group (200X/2000X); (B/E) LPS group (200X/2000X); (C/F) 0.025% DHM + LPS group (200X/2000X); (G/J) 0.05% DHM + LPS group (200X/2000X); (H/K) 0.1% DHM + LPS group (200X/2000X); (I/L) 0.1% DHM group (200X/2000X).
Figure 3 Scanning electron microscope (SEM) observation. SEM observation for ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. (A/D) Control group (200X/2000X); (B/E) LPS group (200X/2000X); (C/F) 0.025% DHM + LPS group (200X/2000X); (G/J) 0.05% DHM + LPS group (200X/2000X); (H/K) 0.1% DHM + LPS group (200X/2000X); (I/L) 0.1% DHM group (200X/2000X).CC BY · PubMed Central
Figure 4 0.025%, 0.05% and 0.1% DHM maintained the barrier function in ileum. Original blots for ZO-1, occluding, claudin-1 and GAPDH (A). Changes of ZO-1 (B), occludin (C) and claudin-1(D) protein expression levels in the ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Values are expressed as the mean ± SD for each group (n = 5). *p < 0.05 and **p < 0.01 represented all groups compared with the control group. #p < 0.05 and ##p < 0.01 represented all groups compared with the LPS group.
Figure 4 0.025%, 0.05% and 0.1% DHM maintained the barrier function in ileum. Original blots for ZO-1, occluding, claudin-1 and GAPDH (A). Changes of ZO-1 (B), occludin (C) and claudin-1(D) protein expression levels in the ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Values are expressed as the mean ± SD for each group (n = 5). *p < 0.05 and **p < 0.01 represented all groups compared with the control group. #p < 0.05 and ##p < 0.01 represented all groups compared with the LPS group.CC BY · PubMed Central
Figure 5 0.025%, 0.05% and 0.1% DHM inhibited LPS-induced ileum apoptosis. Changes of bcl-2 (A), bax (B) and caspase-3 (C) mRNA expression levels in ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Original blots for bcl-2, bax, caspase-3 and GAPDH (D). Changes of bcl-2 (E), bax (F) and caspase-3 (G) protein expression levels in the ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Values are expressed as the mean ± SD for each group (n = 5). *p < 0.05 and **p < 0.01 represented all groups compared with the control group. #p < 0.05 and ##p < 0.01 represented all groups compared with the LPS group.
Figure 5 0.025%, 0.05% and 0.1% DHM inhibited LPS-induced ileum apoptosis. Changes of bcl-2 (A), bax (B) and caspase-3 (C) mRNA expression levels in ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Original blots for bcl-2, bax, caspase-3 and GAPDH (D). Changes of bcl-2 (E), bax (F) and caspase-3 (G) protein expression levels in the ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Values are expressed as the mean ± SD for each group (n = 5). *p < 0.05 and **p < 0.01 represented all groups compared with the control group. #p < 0.05 and ##p < 0.01 represented all groups compared with the LPS group.CC BY · PubMed Central
Figure 6 0.025%, 0.05% and 0.1% DHM inhibited inflammasome formation and pyroptosis activation in LPS-induced ileum injury. Changes of NLRP3 (A), caspase-1 (B) IL-1β (C) and IL-18 (D) mRNA expression levels and IL-1β (E) and IL-18 (F) contents in ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Values are expressed as the mean ± SD for each group (n = 5). *p < 0.05 and **p < 0.01 represented all groups compared with the control group. #p < 0.05 and ##p < 0.01 represented all groups compared with the LPS group.
Figure 6 0.025%, 0.05% and 0.1% DHM inhibited inflammasome formation and pyroptosis activation in LPS-induced ileum injury. Changes of NLRP3 (A), caspase-1 (B) IL-1β (C) and IL-18 (D) mRNA expression levels and IL-1β (E) and IL-18 (F) contents in ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Values are expressed as the mean ± SD for each group (n = 5). *p < 0.05 and **p < 0.01 represented all groups compared with the control group. #p < 0.05 and ##p < 0.01 represented all groups compared with the LPS group.CC BY · PubMed Central
Figure 7 DHM inhibited TLR4/NF-κB signalling pathway and inflammation in LPS-induced ileum injury. Original blots for TLR4, p65, p-p65 and GAPDH (A). Changes of TLR4 (B) protein expression levels, p-p65/p65 ratio (C), IL-6 (D), IL-8 (E), TNF-α (F) and IL-10 (G) mRNA expression levels in ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Values are expressed as the mean ± SD for each group (n = 5). *p < 0.05 and **p < 0.01 represented all groups compred with thecontrol group. #p < 0.05 and ##p < 0.01 represented all groups compared with the LPS group.
Figure 7 DHM inhibited TLR4/NF-κB signalling pathway and inflammation in LPS-induced ileum injury. Original blots for TLR4, p65, p-p65 and GAPDH (A). Changes of TLR4 (B) protein expression levels, p-p65/p65 ratio (C), IL-6 (D), IL-8 (E), TNF-α (F) and IL-10 (G) mRNA expression levels in ileum after 60 mg/kg LPS exposure for 12 h followed by 14 days of 0.025%, 0.05% and 0.1% DHM treatment. Values are expressed as the mean ± SD for each group (n = 5). *p < 0.05 and **p < 0.01 represented all groups compred with thecontrol group. #p < 0.05 and ##p < 0.01 represented all groups compared with the LPS group.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 74

Metadata

Authors
Chang, Y., Yuan, L., Liu, J., Muhammad, I., Cao, C., Shi, C., Zhang, Y., Li, R., Li, C., & Liu, F.
Affiliations
  • Northeast Agricultural University (CN)
  • Harbin Veterinary Research Institute (CN)
Corresponding author
Liu, Fangping
Venue
Veterinary Research
Published
2020-05-24
Volume
51
Issue
1
Pages
72-72
ISSN
  • 0928-4249 (ISSN-L)
  • 1297-9716
OpenAlex
W3028020368
Cited by
74
References
41
Citations by year
2026: 13 · 2025: 10 · 2024: 17 · 2023: 15 · 2022: 13 · 2021: 4 · 2020: 2
FWCI
9.42
Type
journal article
Language
en
Open access
Licence
Locations
  • Veterinary Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (31472241)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal plant effects and applications
  • Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Nutrition and Physiology
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
dihydromyricetin, Escherichia coli lipopolysaccharide, ileal injury, chickens, NLRP3 inflammasome, pyroptosis, intestinal barrier function, oxidative stress, apoptosis, intestinal mucosal injury, flavonoids, intestinal villus morphology
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Animals, Anti-Bacterial Agents, Chickens, Escherichia coli, Escherichia coli Infections, Female, Ileum, Lipopolysaccharides, Poultry Diseases, Signal Transduction, NF-kappa B, Flavonols, Toll-Like Receptor 4, Inflammasomes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dihydromyricetin attenuates Escherichia coli lipopolysaccharide-induced ileum injury in chickens by inhibiting NLRP3 inflammasome and TLR4/NF-κB signalling pathway. https://app.cochat.ai/papers/10.1186/s13567-020-00796-8
The paper
Chang, Y., Yuan, L., Liu, J., Muhammad, I., Cao, C., Shi, C., Zhang, Y., Li, R., Li, C., & Liu, F. (2020). Dihydromyricetin attenuates Escherichia coli lipopolysaccharide-induced ileum injury in chickens by inhibiting NLRP3 inflammasome and TLR4/NF-κB signalling pathway. Veterinary Research. https://doi.org/10.1186/s13567-020-00796-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.